Mother in Bihar seeks justice after vaccine goof-up for her two kids
2 years, 9 months ago

Mother in Bihar seeks justice after vaccine goof-up for her two kids

Hindustan Times  

Poonam Kumari, a postal assistant at the Biharsharif post office in Bihar’s Nalanda district, is in a fix, spending her time trying to sort out how to fix the Covid-19 vaccine certificates of her sons, Piyush Ranjan, 17, and Aryan Kiran, 16. “The officials concerned at the Nalanda civil surgeon’s office were brash when my children last met them in February to correct the mistake in their vaccination certificates. “All I want now is the authorities to correct the mistake in the vaccination certificate because no one will believe me after some time that my children were erroneously administered Covishield when the government’s vaccination certificate mentions Covaxin in it,” she says. “Under the given circumstances, I’ve decided not to vaccinate my children with the second dose unless the government allows them Covishield,” said Kumari. If the certificate mentioning the date of the second jab on October 8 were true, it raises questions how the CoWIN portal allowed Kumar to take the precaution dose within three months, when the rule prescribes a minimum waiting period of nine months from the second dose of the vaccine.

Children Vaccination Bihar Second Certificate Shot My Children Vaccine Kumari Ima Dose Nalanda Covaxin Covishield Dr Kumar Administered Ima Hall  shot  administered  vaccine  seeks  dose  justice  certificate  covid19  bihar  covaxin  vaccination  mother  second  goofup  children  kids

History of this topic

Covishield | Plea in Supreme Court for probe panel for vaccine’s ‘risk factors’
7 months, 3 weeks ago

Covishield | Plea in Supreme Court for probe panel for vaccine’s ‘risk factors’

The Hindu  

The controversy over the safety aspects of the Covishield vaccine reached the Supreme Court on Wednesday, May 1, 2024, with a petition seeking the constitution of an expert medical panel to study the risk factors. Now after the document filed in UK court by the developer of Covishield, we are compelled to think on the risk and hazardous consequences of …

Serum Institute could resume Covishield production as Covid cases rise
1 year, 8 months ago

Serum Institute could resume Covishield production as Covid cases rise

Live Mint  

The Serum Institute of India could resume production of the Covishield Covid-19 vaccine as infections rise in the country, a company spokesperson said on Wednesday. Dr Amitav Banerjee - an epidemiologist who leads DY Patil Medical College in Pune has earlier said that Covishield carried a ‘double whammy of risk’. Many would perhaps not know that Covishield carries a DNA …

Not Permissible To Take One Dose Of Covishield And Another Of Covaxin: Centre To Delhi High Court
1 year, 10 months ago

Not Permissible To Take One Dose Of Covishield And Another Of Covaxin: Centre To Delhi High Court

Live Law  

The Central Government has informed the Delhi High Court that it is not permissible for an individual to take first dose of Covishield and second dose of Covaxin. Central Government’s standing counsel Anurag Ahluwalia told Justice Prathiba M Singh that mixing of two COVID-19 vaccines is not permissible for the first and second dose. The court was hearing a plea …

Government Not Liable To Compensate For Deaths Due To COVID Vaccination : Centre Tells Supreme Court
2 years ago

Government Not Liable To Compensate For Deaths Due To COVID Vaccination : Centre Tells Supreme Court

Live Law  

The Government cannot be held liable to compensate for the deaths occurring due to the administration of COVID-19 vaccines, said the Central Government in an affidavit filed before the Supreme Court.Responding to a petition filed by parents of two girls who died due to the adverse effects of Covishield vaccine, the Union Government submitted that : "The vaccines in use …

COVID-19: Delhi High Court Closes Plea Challenging Centre's Permission For Clinical Trials Of Covaxin Among 2-18 Yrs Old
2 years, 3 months ago

COVID-19: Delhi High Court Closes Plea Challenging Centre's Permission For Clinical Trials Of Covaxin Among 2-18 Yrs Old

Live Law  

The Delhi High Court has disposed of a plea filed during the second wave of COVID-19 against Centre's permission for conducting Phase II and III clinical trials of Covaxin in the age group of 2 to 18 years. A division bench comprising of Chief Justice Satish Chandra Sharma and Justice Subramonium Prasad took note of the Supreme Court's judgment in …

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically
2 years, 4 months ago

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically

News 18  

Individuals who have received Covid-19 vaccines abroad and wish to get their second dose or booster shot in India can now do so. The development comes following an August 18 report by the Times of India which highlighted the issues people who had been jabbed abroad faced when they tried to receive a second or third shot here because the …

Corbevax as Covid booster for adults from August 12. Check details
2 years, 4 months ago

Corbevax as Covid booster for adults from August 12. Check details

India Today  

In a boost to India’s fight against coronavirus, the government gave nod to Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin. Announcing the decision, Union Health minister Mansukh Mandaviya said, “Further Strengthening India's arsenal against Covid-19, Ministry of Health and Family Welfare approves Corbevax as precaution dose for those …

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

Deccan Chronicle  

New Delhi: The government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin, official sources said on Wednesday. "Corbevax will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield …

Corbevax approved as booster for those jabbed with Covishield, Covaxin: Report
2 years, 4 months ago

Corbevax approved as booster for those jabbed with Covishield, Covaxin: Report

Live Mint  

The government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin, news agency PTI has reported on 10 August citing official sources. "Corbevax will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of …

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

India Today  

The government has approved Biological E's Corbevax as a precautionary dose for those above 18 years fully vaccinated with either Covishield or Covaxin, official sources said on Wednesday. "Corbevax will be considered as a precautionary dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines for …

In A First, Biological E's Corbevax Approved As Covid Booster for Covishield, Covaxin Recipients
2 years, 4 months ago

In A First, Biological E's Corbevax Approved As Covid Booster for Covishield, Covaxin Recipients

News 18  

The Centre has approved Biological E’s Corbevax as a Covid-19 precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin. Union Health Secretary Rajesh Bhushan said, “Corbevax will be available as precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines …

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

India TV News  

Highlights Biological E's Corbevax has been approved as a booster or precaution dose. Covid vaccination: Biological E's Corbevax has been approved as a booster or precaution dose for those above the age of 18, and those who are fully vaccinated with either Covishield or Covaxin. "Corbevax will be considered as a precaution dose after completion of six months or 26 …

Govt Nod for Corbevax as Booster for Adults Vaccinated with Covishield, Covaxin Soon
2 years, 4 months ago

Govt Nod for Corbevax as Booster for Adults Vaccinated with Covishield, Covaxin Soon

News 18  

The Union health ministry is expected to soon approve Biological E’s Corbevax as a precaution dose for people above 18 years who are double vaccinated with either Covishield or Covaxin, official sources said on Tuesday. “Corbevax will be considered as a precaution dose after completion of 6 months or 26 weeks from the date of administration of the second dose …

Adults may get different vaccine as booster shot instead of Covishield, Covaxin
2 years, 4 months ago

Adults may get different vaccine as booster shot instead of Covishield, Covaxin

Live Mint  

As the government has continued to emphasize Covid booster doses due to the rising number of cases, a panel has recommended a different vaccine for Indian adults. Government panel National Technical Advisory Group on Immunisation has recommended Biological E's Corbevax as a precaution dose for adults fully vaccinated with either Covishield or Covaxin. "Corbevax may be considered for a third/precaution …

India supplied 23.9 crore COVID-19 vaccine doses to 101 countries, UN entities: Centre
2 years, 5 months ago

India supplied 23.9 crore COVID-19 vaccine doses to 101 countries, UN entities: Centre

Firstpost  

Minister of State for Health Bharati Pravin Pawar said as on 19 July, 2022, a total of 200.34 crore COVID-19 vaccine doses have been administered to beneficiaries above 12 years of age in the country New Delhi: India has supplied 23.9 crore doses of coronavirus vaccine to 101 countries and UN entities in the form of grant, commercial export, or …

Over 13.3 lakh precaution doses of Covid vaccines administered to beneficiaries in 18-59 age group
2 years, 5 months ago

Over 13.3 lakh precaution doses of Covid vaccines administered to beneficiaries in 18-59 age group

India TV News  

Over 13.3 lakh precaution doses of COVID-19 vaccines were administered to beneficiaries in the age group of 18-59 years till 10 pm on Friday, with a majority of those being free under a special 75-day drive launched by the government. The "COVID Vaccination Amrit Mahotsav" to provide free precaution doses of the vaccines to everyone aged 18 years and above …

NTAGI Panel Recommends Use of Covid Vaccines Corbevax, Covaxin for Kids Aged 5-12 Years
2 years, 5 months ago

NTAGI Panel Recommends Use of Covid Vaccines Corbevax, Covaxin for Kids Aged 5-12 Years

News 18  

The NTAGI's Standing Technical Sub-Committee approved the use of COVID-19 vaccines Corbevax and Covaxin for children aged between five and 12 years, official sources said on Friday. Data of Biological E's Corbevax and Bharat Biotech's Covaxin for children aged between five and 12 years were reviewed in the STSC meeting held on June 16 and members decided that the vaccines …

Corbevax, Covaxin vacines get nod for use among 5-12 years olds; details here
2 years, 5 months ago

Corbevax, Covaxin vacines get nod for use among 5-12 years olds; details here

Live Mint  

Biological E's Corbevax and Bharat Biotech's Covaxin on July 8 received the nod from the National Technical Advisory Group on Immunisation's Standing Technical Sub-Committee for use among children aged between 5-12 years. The Drugs Controller General of India granted emergency use authorisation to the Biological E's Corbevax for 5-12 year old and Bharat Biotech's Covaxin for minors belonging to the …

Serum Institute’s Covovax approved by DCGI for children aged 7 to 12 years
2 years, 5 months ago

Serum Institute’s Covovax approved by DCGI for children aged 7 to 12 years

Live Mint  

The Serum Institute Of India's Covid-19 vaccine Covovax has been approved on Tuesday by the Drugs Controller General of India for children between the age group of 7 and 12 years. The DCGI's nod for restricted emergency use in children came after the subject expert committee on Covid-19 of the CSDCO last week recommended granting emergency use authorisation to Covovax …

Govt Panel Recommends Emergency Approval for SII's Covovax for 7-11 Year Olds
2 years, 5 months ago

Govt Panel Recommends Emergency Approval for SII's Covovax for 7-11 Year Olds

News 18  

An expert panel of India's central drug authority on Friday recommended granting emergency use authorisation to Serum Institute's Covovax for children aged 7 to 11 years, official sources said. "The Subject Expert Committee on Covid-19 of the CDSCO deliberated on the EUA application of SII and recommended granting emergency use authorisation for Covovax for children aged 7 to 11 years," …

Corbevax gets DCGI nod as COVID-19 booster after two doses of Covishield or Covaxin
2 years, 6 months ago

Corbevax gets DCGI nod as COVID-19 booster after two doses of Covishield or Covaxin

The Hindu  

Hyderabad-based Biological E. Limited ’s COVID-19 vaccine Corbevax has been approved by the Drug Controller General of India as a heterologous COVID-19 booster dose to individuals aged 18 years and above after 6 months of administration of primary vaccination of Covaxin or Covishield vaccines for restricted use in emergency situations. ‘’Recently, BE furnished its clinical trials data to the DCGI, …

Corbevax Gets DCGI Approval As Covid-19 Vaccine Booster Dose For 18 Years And Above
2 years, 6 months ago

Corbevax Gets DCGI Approval As Covid-19 Vaccine Booster Dose For 18 Years And Above

ABP News  

New Delhi: The Drug Controller General of India approved the Corbevax Covid-19 booster as heterologous Covid-19 booster dose for adults above the age of 18 years who got their primary Covid-19 vaccination of Covishield or Covaxin administered six months before, reported news agency ANI. Recently, BE has furnished its clinical trials data to the DCGI who after a detailed evaluation …

Mix and match of Covid vaccine for booster shots unlikely to be allowed: Report
2 years, 7 months ago

Mix and match of Covid vaccine for booster shots unlikely to be allowed: Report

Live Mint  

The government may not allow the administration of a precaution Covid-19 dose that is different from the one used for primary vaccination, reported news agency PTI, quoting sources, on Thursday. This comes in light of a recent study by the Christian Medical College Vellore, which showed that a booster dose of Covishield after primary vaccination with Covaxin gives 6 to …

Biological E seeks EUA of Corbevax as booster for Covishield, Covaxin recipients
2 years, 7 months ago

Biological E seeks EUA of Corbevax as booster for Covishield, Covaxin recipients

Live Mint  

Hyderabad-based Biological E has submitted an application to India's drug regulator, seeking emergency use authorisation for its Covid-19 vaccine Corbevax as a booster dose for adults who have been given two doses of either Covishield or Covaxin, reported news agency PTI, quoting sources. “We are now submitting the marketing authorization application for grant of permission Corbevax for restricted use in …

Jabs for Kids, Reducing Gap Between Doses for Those Travelling Abroad on Agenda as NTAGI Meets Today
2 years, 7 months ago

Jabs for Kids, Reducing Gap Between Doses for Those Travelling Abroad on Agenda as NTAGI Meets Today

News 18  

As India witnesses a surge in coronavirus cases once again, the Covid-19 working group of the National Technical Advisory Group on Immunisation will meet at noon on Wednesday to discuss reducing the gap between the second dose and the precaution dose for people traveling abroad as well as vaccinations for 5-12 and 6-12 age groups. Last week, India’s drug regulator …

SII's Covid Vaccine Covovax Now Available for 12-17 Age Group at Private Centres
2 years, 7 months ago

SII's Covid Vaccine Covovax Now Available for 12-17 Age Group at Private Centres

News 18  

Children aged 12 to 17 years can now get the Serum Institute's coronavirus vaccine Covovax at private centres with a provision for it being made on the CoWIN portal, official sources said on Monday. "Those aged 12-17 age group can now opt for Covovax shot at private hospitals. India's drug regulator had approved Covovax for restricted use in emergency situations …

No Haste In Granting Emergency Use Authorization To Covaxin & Covishield: Supreme Court
2 years, 7 months ago

No Haste In Granting Emergency Use Authorization To Covaxin & Covishield: Supreme Court

Live Law  

In its judgment holding that the policy of the Union Government on COVID-19 vaccination policy is reasonable, the Supreme Court rejected the contention that restricted emergency use approvals had been granted to COVISHIELD and COVAXIN in haste, without thorough review of the relevant data.The court observed that the challenge to the procedures adopted by the expertbodies while granting. "However, it …

SEC seeks more data from Serum Institute of India over COVID vaccine 'Covovax' for 7-12 age group: Sources
2 years, 7 months ago

SEC seeks more data from Serum Institute of India over COVID vaccine 'Covovax' for 7-12 age group: Sources

India TV News  

Highlights DCGI subject expert committee on April 29 sought more data from SII on Covovax vaccine SEC has sought more data for Covovax vaccine for 7-12 years age group Covovax has already been recommended by DCGI for children above 12 years of age Coronavirus vaccine: The Drugs Controller General of India's subject expert committee on Friday sought more data from …

In haste: The Hindu Editorial on vaccinating children against COVID-19
2 years, 7 months ago

In haste: The Hindu Editorial on vaccinating children against COVID-19

The Hindu  

The emergency use authorisation granted on April 26 to two COVID-19 vaccines — Corbevax for children 5-11 years, and Covaxin for children 6-11 years — is one more instance where the Indian drug regulator has acted in haste. Even if the EUA granted to Covaxin in January 2021 despite no safety and efficacy data of the phase-3 trial is condoned …

PM Modi tells states: Covid-19 not over yet, give kids jabs swiftly
2 years, 7 months ago

PM Modi tells states: Covid-19 not over yet, give kids jabs swiftly

Deccan Chronicle  

New Delhi: Prime Minister Narendra Modi urged all chief ministers on Wednesday to remain alert as “the threat of Covid-19 was not fully over.” During an interaction with the chief ministers on the emerging Covid-19 situation in the country, he also said that the government's priority was to vaccinate all eligible children at the earliest with special campaigns needed in …

COVID: Over 2,900 new pandemic cases, 32 fatalities in last 24 hours; active cases rise to 16,279
2 years, 7 months ago

COVID: Over 2,900 new pandemic cases, 32 fatalities in last 24 hours; active cases rise to 16,279

India TV News  

Highlights Total active cases of COVID in India have rose to 16,279 today The total death toll in the country is now at 5,23,654 The daily positivity rate is 0.58 per cent on April 27 COVID-19 India News Updates : India recorded 2,927 new cases of the novel coronavirus, along with 32 deaths due to the infection in the past …

Covaxin Gets DCGI Nod for Kids Aged 6-12 Yrs; Corbevax Cleared for 5-12 Yr Olds; 12+ to Get Zydus Jab
2 years, 7 months ago

Covaxin Gets DCGI Nod for Kids Aged 6-12 Yrs; Corbevax Cleared for 5-12 Yr Olds; 12+ to Get Zydus Jab

News 18  

In a move that could mitigate the vulnerability of children to the SAR-COV-2 virus, the Drug Controller General of India gave a restricted emergency use authorisation to three vaccines — Bharat Biotech’s Covaxin, Biological E’s Corbevax and Zydus Cadila’s ZyCov-D — for various age groups of children. Last week, the expert panel of India’s apex drug regulator recommended grant of …

Vaccine for kids: DCGI grants emergency use nod to 3 Covid vaccines for different age group of children
2 years, 7 months ago

Vaccine for kids: DCGI grants emergency use nod to 3 Covid vaccines for different age group of children

India TV News  

Highlights India began inoculating children aged 12-14 on March 16 Countrywide vaccination drive was rolled out on January 16 last year Precaution doses to all aged above 18 yrs were allowed at private vaccination centres from April 10 Vaccine for Kids: The Drugs Controller General of India on Tuesday approved three Covid vaccines for the restricted emergency use authorisation for …

India Could Start Vaccinating Younger Kids Soon as Govt Panel Suggests Covaxin for 6-12 Age Group​ - News18
2 years, 8 months ago

India Could Start Vaccinating Younger Kids Soon as Govt Panel Suggests Covaxin for 6-12 Age Group​ - News18

News 18  

Amid a resurgence of Covid-19 cases, especially among children, the focus is back on vaccinating kids and now, there are indications from the government that India could soon start coronavirus jabs for younger children. Covaxin in the 6-12 age group The Subject Expert Committee has recommended Bharat Biotech’s Covaxin to the Drug Controller General of India for children aged between …

Bharat Biotech asked to provide more data on Covaxin for below 12-year-olds
2 years, 8 months ago

Bharat Biotech asked to provide more data on Covaxin for below 12-year-olds

Deccan Chronicle  

New Delhi: The Subject Expert Committee of the Drug Controller General of India has asked Bharat Biotech for additional data on its COVID-19 vaccine, Covaxin, for administering it to children aged between 2-12 years, sources said. This development comes after the Subject Expert Committee discussed recommendations for the restricted emergency of Covaxin in children aged between 2-12 years. However, the …

Govt panel approves use of Corbevax for 5-12 year age group
2 years, 8 months ago

Govt panel approves use of Corbevax for 5-12 year age group

India Today  

Expert panel of Drug Controller General of India -- India’s drug regulator-- has recommended granting emergency use authorisation for Biological E's Covid-19 vaccine Corbevax for children in 5 to 12 years age group. "The Subject Expert Committee on COVID-19 of the CDSCO which deliberated on Biological E's EUA application has recommended granting emergency use authorisation for use of Corbevax in …

19 Year Old Allegedly Dies Post Covishield Vaccination: Kerala High Court Seeks Centre's Response On Parents' Plea
2 years, 8 months ago

19 Year Old Allegedly Dies Post Covishield Vaccination: Kerala High Court Seeks Centre's Response On Parents' Plea

Live Law  

The parents of a 19-year-old student have moved the Kerala High Court seeking justice alleging that their daughter died due to the compulsory administration of the Covishield vaccine and they have sought Rs 1 crore as compensation for the death of their only daughter.Justice N Nagaresh has sought the view of the central government on the petition.The petitioners' daughter, a …

Serum Institute to Give Free Covishield Vials to Private Vaccination Centres to Compensate for Price Difference
2 years, 8 months ago

Serum Institute to Give Free Covishield Vials to Private Vaccination Centres to Compensate for Price Difference

News 18  

A day after slashing the price of the precaution dose of Covishield to Rs 225 per shot for private hospitals, the Serum Institute of India told the Centre on Sunday that it will compensate for the price difference for the unexpired stocks lying with private centres in the form of free vials of fresh stocks, official sources said. Vaccine majors …

Covid-19 precaution dose for 18+ age group from today. Check eligibility, price and how to book
2 years, 8 months ago

Covid-19 precaution dose for 18+ age group from today. Check eligibility, price and how to book

India Today  

From Sunday onwards, all adults in the country are eligible to get booster vaccine doses against Covid-19, the central government had announced earlier this week. The Covid-19 precaution doses or booster shots will be available for all adults at private vaccination centres and will be administered on payment of a fee. PRICE Except for healthcare workers, frontline workers and the …

COVID: Over 1 crore vaccine doses administered to 12-14 age group
2 years, 8 months ago

COVID: Over 1 crore vaccine doses administered to 12-14 age group

India TV News  

Highlights India's vaccination coverage against COVID pandemic crossed 182.83 crore mark Over 2.23 cr Precaution Doses for identified categories of beneficiaries have been administered India on Friday reported marginal decline at 1,685 fresh Covid infection with 83 deaths More than 1 crore COVID-19 vaccine doses have been administered to those in the 12-14 years age group since the beginning of …

India's drugs regulator approves phase-3 trial of covid vaccine covovax
2 years, 9 months ago

India's drugs regulator approves phase-3 trial of covid vaccine covovax

India Today  

The Drugs Controller General of India granted permission on Wednesday for conducting the phase-3 clinical trial of Covid-19 vaccine Covovax as a booster dose in adults, official sources said. The Subject Expert Committee on Covid-19 of the Central Drugs Standard Control Organisation had, on March 5, recommended permission for conducting the phase-3 clinical trial for Covovax as a booster dose …

All adults may be cleared for COVID-19 booster doses
2 years, 9 months ago

All adults may be cleared for COVID-19 booster doses

Deccan Chronicle  

New Delhi: India is considering making all adults eligible for Covid-19 booster doses in view of a surge in infections in some countries and to ease difficulties being faced during international travel. Only healthcare and frontline workers and those older than 60 years are now allowed to take booster doses in India, whether free in government centres or paid for …

Covid-19: Delhi High Court Seeks Centre's Report On Policy For Vaccination Of Children Below 12 Yrs
2 years, 9 months ago

Covid-19: Delhi High Court Seeks Centre's Report On Policy For Vaccination Of Children Below 12 Yrs

Live Law  

The Delhi High Court on Monday asked the Centre to file a report indicating the steps taken by it for vaccination of children below the age of 12 years, against Covid-19.The Division Bench of Acting Chief Justice Vipin Sanghi and Justice Navin Chawla directed the Centre to file its response before the next date of hearing, May 12.The direction was …

Why India's vaccine advisory body recommends reducing second-dose gap for Covishield
2 years, 9 months ago

Why India's vaccine advisory body recommends reducing second-dose gap for Covishield

Firstpost  

The National Technical Advisory Group on Immunisation has recommended that the gap between the first and second dose of Covishield should be reduced to eight to 16 weeks, from the current gap of 12 to 16 The National Technical Advisory Group on Immunisation has recommended that the gap between the first and second dose of Covishield should be reduced to …

Covid-19 Inoculation Drive for Children in 12-14 Age Group to Begin on Mar 23 in Madhya Pradesh: Official
2 years, 9 months ago

Covid-19 Inoculation Drive for Children in 12-14 Age Group to Begin on Mar 23 in Madhya Pradesh: Official

News 18  

The vaccination drive against coronavirus for the children in the age group of 12 to 14 years will begin in Madhya Pradesh on March 23 for which 30 lakh doses of Corbevax vaccine have been received, a senior health official said on Saturday. The national vaccination drive for the children in the 12-14 age group began on March 16. “We …

AP targets first dose of CorBevax for 14.9 lakh children
2 years, 9 months ago

AP targets first dose of CorBevax for 14.9 lakh children

Deccan Chronicle  

Vijayawada: The Andhra Pradesh government aims to administer the Covid-19 vaccine, called CorBevax, to 14.90 lakh children aged between 12 and 14 years by taking up a special campaign in schools from March 21. Though state health authorities started administering the Covid jab to the targeted children at Covid Vaccination Centres from March 16 in the state, they will be …

COVID-19: Over 3 lakh doses of Corbevax vaccine given to children aged 12-14 years on day 1
2 years, 9 months ago

COVID-19: Over 3 lakh doses of Corbevax vaccine given to children aged 12-14 years on day 1

Firstpost  

The vaccination against COVID-19 in this age group started on Wednesday with Biological E’s intramuscular vaccine, two doses of which are to be administered 28 days apart New Delhi: Over 3 lakh children between 12 and 14 years have received their first shot of Covid vaccine taking the total doses administered in the country to over 180.80 crore, according to …

Over 3 lakh doses of Covid vaccine given to children aged 12-14 yrs on day 1
2 years, 9 months ago

Over 3 lakh doses of Covid vaccine given to children aged 12-14 yrs on day 1

Deccan Chronicle  

New Delhi: Over 3 lakh children between 12 and 14 years have received their first shot of Covid vaccine taking the total doses administered in the country to over 180.80 crore, according to Union Health Ministry data. The vaccination against COVID-19 in the age group of 12-14 years started on Wednesday with Biological E's intramuscular vaccine Corbevax, two doses of …

India begins COVID-19 vaccine for kids aged 12-14 years, booster for all above 60 from today; All you need to know
2 years, 9 months ago

India begins COVID-19 vaccine for kids aged 12-14 years, booster for all above 60 from today; All you need to know

Firstpost  

The Centre has released guidelines for COVID-19 vaccination of children between 12-14 years. Two doses of Biological E’s intramuscular vaccine Corbevax would be administered at an interval of 28 days Expanding India’s universal COVID-19 vaccination drive, health ministry has announced vaccination program for children aged 12-14 years and precautionary dose for everyone above the age of 60, removing the co-morbidity …

COVID: Over 2 crore precaution doses administered among eligible beneficiaries, says Mansukh Mandaviya
2 years, 9 months ago

COVID: Over 2 crore precaution doses administered among eligible beneficiaries, says Mansukh Mandaviya

India TV News  

Highlights India has so far administered over 2 cr precaution doses among the eligible beneficiaries Over 97% of India's adult population have also received their 1st dose of vaccine against COVID Health Min Mansukh Mandaviya requested eligible beneficiaries to get their 3rd shot at the earliest India has so far administered over 2 crore precaution doses or the third vaccine …

Discover Related